SAPUPPO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.405
EU - Europa 1.002
AS - Asia 910
AF - Africa 114
SA - Sud America 104
OC - Oceania 1
Totale 3.536
Nazione #
US - Stati Uniti d'America 1.362
IT - Italia 386
SG - Singapore 379
RU - Federazione Russa 317
CN - Cina 283
BR - Brasile 80
KR - Corea 77
VN - Vietnam 70
CI - Costa d'Avorio 65
NL - Olanda 47
FR - Francia 40
IE - Irlanda 36
BD - Bangladesh 31
CA - Canada 30
DE - Germania 29
GB - Regno Unito 28
SE - Svezia 28
NG - Nigeria 20
IN - India 19
FI - Finlandia 17
HK - Hong Kong 11
AR - Argentina 10
PL - Polonia 10
BJ - Benin 9
CZ - Repubblica Ceca 9
ES - Italia 9
MX - Messico 9
JP - Giappone 8
UA - Ucraina 8
SN - Senegal 7
AL - Albania 6
LT - Lituania 6
ZA - Sudafrica 6
IQ - Iraq 5
CL - Cile 4
MD - Moldavia 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CO - Colombia 3
ID - Indonesia 3
PK - Pakistan 3
PY - Paraguay 3
TR - Turchia 3
AT - Austria 2
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
GA - Gabon 2
GR - Grecia 2
KG - Kirghizistan 2
MT - Malta 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
TN - Tunisia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
IR - Iran 1
KZ - Kazakistan 1
MA - Marocco 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.536
Città #
Dallas 260
Singapore 259
Houston 172
San Jose 154
Santa Clara 153
Moscow 151
Hefei 120
Chandler 81
Seoul 77
Chicago 71
Abidjan 65
Ashburn 59
Los Angeles 54
Beijing 41
Dublin 36
Civitanova Marche 35
Rome 35
Catania 28
Boardman 26
Lauterbourg 23
Buffalo 22
New York 20
Montreal 18
Ho Chi Minh City 17
Milan 15
Amsterdam 14
Council Bluffs 14
Hanoi 11
Hong Kong 11
Palermo 11
São Paulo 11
Abuja 10
Grafing 10
Lagos 10
Naples 10
Cotonou 9
Andover 8
Cambridge 8
Lappeenranta 8
Lawrence 8
Marseille 8
Munich 8
Orem 8
Tokyo 8
Warsaw 8
Bari 7
Brooklyn 7
Chennai 7
Columbus 7
Dakar 7
Nanjing 7
Toronto 7
Aci Castello 6
Atlanta 6
Boston 6
Brno 6
London 6
Turin 6
Bremen 5
Caserta 5
Charlotte 5
Da Nang 5
Genoa 5
Haiphong 5
Johannesburg 5
Misterbianco 5
Padova 5
Poplar 5
San Francisco 5
Stockholm 5
The Dalles 5
City of London 4
Denver 4
Florence 4
Frankfurt am Main 4
Helsinki 4
Jacksonville 4
Kochi 4
Modena 4
Reggio Emilia 4
Rio de Janeiro 4
Rose 4
Turku 4
Valledolmo 4
Wilmington 4
Acalanes Ridge 3
Bergamo 3
Bologna 3
Brussels 3
Can Tho 3
Des Moines 3
Guangzhou 3
Hebei 3
Kyiv 3
Madrid 3
Paris 3
Phoenix 3
Querétaro 3
Ragusa 3
Saint Petersburg 3
Totale 2.436
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 291
Valore predittivo di recidiva/persistenza di malattia della VII e VIII edizione del sistema di stadiazione TNM e del sistema di stratificazione del rischio (2015 e 2009) dell'American Thyroid Association in una serie prospettica consecutiva di 451 pazienti con carcinoma differenziato tiroideo. Proposta di un nomogramma predittivo di recidiva o persistenza di malattia 289
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 220
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 167
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 155
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 148
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 141
Lymph node location is a risk factor for papillary thyroid cancer-related death 139
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 134
Orbital metastasis from thyroid cancer: a case report and review of the literature 132
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 124
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 122
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 120
Is multifocality a risk factor in low-risk papillary thyroid cancer? 114
Prognostic factors for adrenocortical carcinoma outcomes 113
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 108
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 107
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 105
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 103
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 102
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 100
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 98
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center 97
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 96
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 93
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 84
Gender Impact on Safety and Efficacy in Lenvatinib treated patients with radioiodine-refractory Differentiated Thyroid Cancer (GISEL study) 67
Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer 3
Totale 3.572
Categoria #
all - tutte 9.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202246 1 7 0 3 8 0 8 2 3 0 1 13
2022/2023191 9 12 3 35 12 25 5 36 40 0 5 9
2023/2024187 14 20 2 3 2 53 0 18 0 2 19 54
2024/2025766 15 100 57 59 120 99 34 34 28 66 73 81
2025/20262.151 138 205 331 145 259 419 194 44 162 103 103 48
Totale 3.572